giiant pharma inc.

📍 Montreal, Canada🗓 Founded 2014👥 5 employees💰 Last funded May 2021
Biotechnology Research🌐 giiant.com
Website LinkedIn
Giiant is a preclinical-stage biotech company, with its proprietary Precision Delivery technology platform, designs gut-restricted, tissue-specific, small molecule, drug therapeutics with various biological targets in gastroenterology. Its lead program GT-2108 is a microbiota-activated PDE4 inhibitor prodrugs, with improved drug tolerability and enhanced therapeutic effect.
2
Total investors
0
Early stage
0
Mid stage
2
Late stage
2014
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Canada
2
Frequently asked questions
Who invested in giiant pharma inc.?
giiant pharma inc. has 2 investors on record on gritt.io and 2 late-stage investors.
When did giiant pharma inc. last raise funding?
The most recent investment in giiant pharma inc. recorded on gritt.io was in May 2021.
When was giiant pharma inc. founded?
giiant pharma inc. was founded in 2014.
What industry is giiant pharma inc. in?
giiant pharma inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is giiant pharma inc. based?
giiant pharma inc. is headquartered in Montreal, Canada.